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Treatment patterns for cancer in Western Australia:
does being Indigenous make a difference?
^
Sonja
E Hall, Caroline E Bulsara, Max K Bulsara, Timothy G Leahy, Margaret R Culbong, Delia Hendrie and C D'Arcy J Holman

T

here is little documented research
examining disparities in cancer services between the Indigenous and
non-Indigenous populations of Australia.
Surgical procedures for cancer have received
almost no attention, although differences
have been seen between Indigenous patients
and other
patientsJournal
in utilisation
of hospital
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combined.1,2 Inequalities in access to
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Furthermore, living in a rural
reported.
Research
area in
Australia has been shown to affect
cancer treatment patterns,4,5 and being
treated in a rural hospital has been shown to
worsen patient outcomes.4,5 The finding of a
lower total procedure rate in the Indigenous
population1,2 is consistent with these findings.
Our exploratory study aimed to examine
possible disparities between the Indigenous
and non-Indigenous populations of Western
Australia (WA) in the uptake of cancer
surgery for three common cancers (breast,
prostate and lung), using administrative
data collected routinely over 20 years.
METHODS
Data sources and patients
The WA Record Linkage Project was used to
extract all hospital morbidity, cancer registrations and death records for all residents of
WA who:
• had a mention in any record of cancer of
the breast (codes, ICD-9 1746 or ICD-10
C507), prostate (ICD-9 185 or ICD-10 C61)
or lung (ICD-9 162 or ICD-10 C33); or,
• if there was no cancer registration, had a
hospital record with the cancer identified
together with an associated procedure.

ABSTRACT
Objective: To examine whether hospital patients with cancer who were identified as
Indigenous were as likely to receive surgery for the cancer as non-Indigenous patients.
Design, setting and patients: Epidemiological survey of all Western Australian (WA)
patients who had a cancer registration in the state-based WA Record Linkage Project
that mentioned cancer of the breast (1982–2000) or cancer of the lung or prostate
(1982–2001).
Main outcome measures: The likelihoods of receiving breast-conserving surgery or
mastectomy for breast cancer, lung surgery for lung cancer, or radical or non-radical
prostatectomy for prostate cancer were compared between the Indigenous and
non-Indigenous populations using adjusted logistic regression analyses.
Results: Indigenous people were less likely to receive surgery for their lung cancer
(odds ratio [OR], 0.64; 95% CI, 0.41–0.98). Indigenous men were as likely as nonIndigenous men to receive non-radical prostatectomy (OR, 0.69; 95% CI, 0.40–1.17); only
one Indigenous man out of 64 received radical prostatectomy. Indigenous women were
as likely as non-Indigenous women to undergo breast-conserving surgery (OR, 0.86;
95% CI, 0.60–1.21).
Conclusions: These results indicate a different pattern of surgical care for Indigenous
patients in relation to lung and prostate, but not breast, cancer. Reasons for these
disparities, such as treatment choice and barriers to care, require further investigation.
MJA 2004; 181: 191–194

Patients were included if they had an
incident date for breast cancer between 1
January 1982 and 31 December 2000, or,
for prostate or lung cancer, between 1 January 1982 and 31 December 2001. As breast
cancer data were extracted earlier, the 2001
data were incomplete and not used.
Data extraction
The Record Linkage Project contains data
for each patient for each hospital admission.
The first record that mentioned the cancer of
interest was labelled the index admission;
any cancer or death record details were
added to this record.
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Patient age and marital status at the time
of the index admission were used to adjust
for confounding in the logistic regression
models. Other variables were created for use
in the regression model, including:
Indigenous status. Due to variability in the
recording of this status, any mention in any
hospital, cancer or death record was added
to the index admission record.
Calendar period. For breast cancer, the date
of diagnosis was categorised as 1982–1986,
1987–1991, 1992–1996 or 1997–2000; for
lung cancer, the final category was 1997–
2001. As diagnoses of prostate cancer
increased greatly when testing for prostatespecific antigen (PSA) was added to the
Medicare Benefits Schedule in 1993,8 date of
diagnosis was categorised as pre-, peri- or
post-PSA testing (1982–1992, 1993–1996
and 1997–2001, respectively).
Comorbidity. ICD codes in the hospital morbidity records for the index admission and
admissions in the previous year (excluding
the cancer of interest) were used to adjust
for comorbidity using the Charlson Morbidity Index.9
191

R ES E A R C H

Indices of disadvantage. The Index of Relative
Socioeconomic Disadvantage (IRSD)10 and
the Accessibility/Remoteness Index of Australia (ARIA)11 for the place of residence
were added to the record based on the
Australian Bureau of Statistics census collection districts (where unavailable, the postcode was used). The hospital of the index
admission was categorised as public or private and as metropolitan or rural. The payment classification of the patient at the
index admission was recoded as public or
private.
Definitions of surgery. Lung cancer surgery
was defined as one or more of pneumonectomy, lobectomy, segmentectomy, wedge
resection or excision/resection of the bronchus or endotrachea. Prostate cancer surgery
was defined as either radical or non-radical
prostatectomy (including closed, transurethral, or open). For breast cancer, only
women who underwent mastectomy or
breast-conserving surgery were included, as
the principal aim was to examine differences
in patterns of surgical treatment rather than
use of surgery per se. There were no Indigenous non-surgery breast cancer cases.

1 Demographic characteristics of cancer patients in Western Australia,
1982–2001, and proportions who underwent surgery
Non-Indigenous

Indigenous

P

Lung cancer
Total with lung cancer (% of all cases)

13103 (98.0%)

274 (2.0%)

Age in years (mean [SD])

67.4 (11.1)

61.7 (12.5)

< 0.01

Number who were male (%)

9222 (70.4%)

159 (58.0%)

< 0.01

Received lung cancer surgery (%)

1693 (12.9%)

26 (9.5%)

Age in years (mean [SD])

64.0 (10.5)

Number who were male (%)

1160 (68.5%)

61.8 (11.7)
15 (57.7%)

0.08
0.29
0.24

Prostate cancer
Men with prostate cancer (% of all cases)
Age in years (mean [SD])
Received radical prostatectomy (%)
Age in years (mean [SD])
Received non-radical prostatectomy (%)
Age in years (mean [SD])

14123 (99.5%)
72.0 (9.3)
1787 (12.7%)
61.7 (6.5)
5770 (40.8%)
73.8 (8.3)

64 (0.5%)
72.4 (11.5)
1 (1.5%)

0.79
0.01

*
24 (35.3%)
71.4 (13.2)

0.002
0.15

Breast cancer
Women who had breast cancer surgery (%)
Age in years (mean [SD])
Received breast-conserving surgery rather than
mastectomy (%)
Age in years (mean [SD])

11055 (98.6%)

151 (1.4%)

58.5 (14.0)

57.5 (13.6)

5243 (47.6%)
57.6 (14.0)

71 (47.0%)
57.6 (13.1)

0.37
0.98
0.97

* As only one Indigenous man underwent radical prostatectomy, his age is omitted to prevent identification.

Statistical analysis
Univariate analysis was carried out, followed
by crude and adjusted logistic regression
analysis of the likelihood of receiving surgery for lung and prostate cancer, or breastconserving surgery for breast cancer. The
adjusted analyses used the demographic,
comorbidity and disadvantage indices (Box
1). For age, the Box–Tidwell term (age ×
ln[age]) was used to provide a better fit of
the model for adjustment purposes. The
data were analysed using SPSS for Windows
(Version 10.0.7.)12 and Stata 8.13
The study was approved by the Human
Research Ethics Committee of the University
of Western Australia.
RESULTS
The Indigenous population accounted for
2% of lung cancer cases. The Indigenous
patients were younger and more likely to be
female than the non-Indigenous patients
(Box 1). Among the lung cancer patients
who received surgical intervention, age and
sex distribution were similar in the Indigenous and non-Indigenous groups. There
was a tendency for Indigenous cases to not
receive surgery, although this only reached
significance with the longer time period
(1982–2001) (Box 2).
192

Very few Indigenous men were recorded
as having prostate cancer. The mean age of
the Indigenous and non-Indigenous groups
was similar. A much smaller proportion of
Indigenous patients received radical or nonradical prostatectomy (Box 1). As only one
Indigenous person received a radical prostatectomy, logistic regression was not performed. The likelihood of receiving nonradical prostatectomy was lower for Indigenous patients than for non-Indigenous
patients in the demographically adjusted
model but not in the fully adjusted model
(Box 2).
Among women with breast cancer there
was no difference between Indigenous and
non-Indigenous groups in the proportion
who received breast-conserving surgery
(Box 1). Likewise, the ages of the groups
were similar. Logistic regression showed that
Indigenous women had similar treatment
patterns to non-Indigenous women (Box 2).
DISCUSSION
In general, the Indigenous population with
lung or prostate cancer were less likely to
receive a surgical procedure for their cancer
than the non-Indigenous population. However, Indigenous women with breast cancer
MJA • Volume 181 Number 4 • 16 August 2004

had a pattern of surgery similar to that of
non-Indigenous women.
Age-standardised cancer incidence rates
have tended to be lower in the Indigenous
population than in the non-Indigenous population.14 In part, this may be attributable to
known difficulties in identifying all Indigenous people in the hospital, cancer and
death registries,15 which would result in the
true effect of being Indigenous being underestimated. Furthermore, poor life expectancy for Indigenous people may mask
cancers that are latent at the time of early
death. The small numbers of diagnosed and
identified cases limit the potential of the
statistical analysis to illuminate treatment
patterns and outcomes in the Indigenous
population.
There is some evidence that Indigenous
people with cancer in Australia generally
have higher case fatality rates.16 This may be
due to a higher relative incidence of cancers
with high fatality, particularly lung cancer,14,17 later diagnosis or suboptimal treatment patterns. We found no difference in
breast cancer treatment patterns, whereas
there were differences in lung and prostate
cancer treatment patterns.
Sociocultural and economic factors may
influence treatment patterns and outcomes,
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patterns in the non-Indigenous population,
but their use will remain limited in the
Indigenous population unless sufficient
cases are available for analysis. This could be
achieved by better identification of the
Indigenous population in the datasets and
interstate cooperation to merge de-identified
data. Finally, Indigenous issues must be
embedded in cancer control strategy plans,
and they must be implemented.

2 Odds ratio of receiving cancer surgery for Indigenous people versus
non-Indigenous people in Western Australia
1982-2001
(adjusted demographically)*
Lung cancer surgery
Non-radical prostatectomy
Breast-conserving surgery†
1991-2001
(adjusted demographically)*
Lung cancer surgery
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Breast-conserving surgery†
1991-2001
(adjusted for disadvantage)‡
Lung cancer surgery
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